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Parasitic helminth infections are highly prevalent worldwide, however the distribution of 
infections shows they are much more prevalent in developing countries. The distribution 
of Inflammatory Bowel Diseases (IBD) and allergies shows that they are inversely 
related to parasitic infections; countries with high burden of parasitic helminth infection 
show fewer cases of IBDs and allergies. This review examines a potential causal link 
between higher parasitic helminth infection and lower incidence of IBD and allergies. 
The focus will be the characteristics of a type 2 immune response and the interactions 
between a parasite and host upon infection (these two pathologies have many 
overlapping features and the regulation of the parasite within the host can have effects 
on the type 2 response), and the interaction of a type 2 response with IBD and allergies. 
Furthermore, current research that shows the gross applications of these interactions to 
IBD and allergy treatment, and the current direction of the field, will be discussed.  
 
Introduction:  
Helminth infections are highly prevalent in our world with global reports estimating 
nearly one-third of the global population playing host to a helminth infection (1). This 
ranks helminths as one of the most prevalent groups of infectious agents in the world. 
Along with infection come many side effects that can be potentially dangerous. Helminth 
infections have been prevalent in humans for such a long time that, not only have the 
parasites themselves developed resistance to immune expulsion, but humans have also 
evolved to limit the effects felt by helminth infections. These coevolutionary events have 
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led to a symbiotic relationship where the host manages the symptoms, and does not 
expel the parasite due to the risk of greater injury. 
 This relationship has led to some interesting correlations showing how, when it 
comes to certain conditions like allergies and Irritable Bowel Syndrome (including 
Crohn’s Disease and Ulcerative Colitis) the presence of a parasite in the host can have 
a beneficial effect. It has been shown that infection with parasites, such as helminths, 
can greatly reduce the symptoms related to these conditions. However, persistent 
helminth infections are not a suitable treatment option, due to their unpredictability and 
side effects.  
 Ultimately, the goal would be to mimic the presence of a parasite in the body, 
instead of actually treating the patient with a parasite. In order to mimic the effects we 
need to study the mechanisms, present in parasite infection, that give rise to its 
beneficial effect. If we are able to discover the specific proteins, cytokines, or mediators 
that provide a beneficial effect, and deliver them directly to the host, that would be an 
ideal therapy for these diseases.  
 To understand potential therapeutic agents, we first must understand the 
relationship between the parasite and the host. The mutually beneficial 
immunosuppressive type 2 immune response dominates during parasitic helminth 
infection and whilst it is well established that parasitic helminths contribute to driving this 
type 2 response, the exact molecular mechanisms used by the parasites to manipulate 
the host immune response are not well understood. A clearer appreciation of the host-
parasite interface is required before we can therapeutically exploit helminths or their 
modulatory molecules as a treatment for conditions such as allergies and IBD.  
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Type 2 Immune Response: 
 Allergies and certain chronic diseases can be a result of inappropriate type 2 
immune responses, and by over-reaction of the host due to sensitization. Typical type 2 
responses have specific mediators and characteristic changes that occurs. The most 
common type 2 mediators are cytokines such as interleukin (IL)-4, IL-5, IL-9 and IL-13. 
Other common characteristics are eosinophilia, mast cell activation, goblet cell 
proliferation, increased secretions, and elevated levels of reactive immunoglobulin (Ig)E.  
 The cardinal sign of a type 2 response is the presence of Th2 cells, which are the 
key modulators of the whole response. Once initially stimulated by IL-4, Th2 cells are 
induced from naïve CD4+ cells. Th2 cells then help to orchestrate the entire type 2 
response by secreting more IL-4 as well as IL-5 and IL-13. Th2 also facilitates B cell 
class switching, to produce IgE antibodies. Th2 cells also play a role in the progression 
of all of the other changes that occur with a type 2 response. Without Th2 cells, there 
would be no type 2 immune response.  
 IL-4 has two main effects, initially it helps to recruit more naïve CD4+ cells to 
become Th2 cells, and later it is the main inducer of antibody isotope switching to IgE. 
IL-5 and IL-9 are important for the recruitment and activation of eosinophils and mast 
cells. IL-13 is responsible for goblet cell hyperplasia and for the elevated levels of 
secretions and hyper-responsiveness. These are the main cytokines in the type 2 
response, although there are many others that play roles in the immune system, these 
are the most understood for type 2 immune responses.  
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 Eosinophilia is an elevation in the number of eosinophils in the tissues and blood 
stream, typically eosinophilia is determined when the eosinophil count is greater than 
450-550 cells/microliter. Eosinophils are important cells in the type 2 response, hence 
why there is an elevation upon parasitic infection. They are responsible for inducing 
inflammation upon release of their granules. Overactivation of eosinophils can lead to 
uncontrolled inflammation and potentially chronic inflammation. Historically eosinophils 
were only thought to be part of the late stage of a type 2 response, in which they are 
used in the fight against the parasite. However, recent studies have shown that 
eosinophils are present in the early stages of a type 2 response, and also have inducing 
effects for the type 2 response. It has been found that eosinophils produce IL-4, IL-6 
and IL-13 early in the development of a type 2 response. The activation of Th2 cells by 
eosinophils is a good example of the interconnectivity between the innate and adaptive 
immune systems, and help explain the response to Th2 antigens, even in the absence 
of adaptive immune cells. (15,16)  
 Mast Cells are important cells for the late stages of a type 2 response, releasing 
their histamine containing granules to promote an inflammatory response. In cases of 
repeated type 2 antigen exposure, mast cell hyperplasia is seen. Bone marrow derived 
mast cell progenitors circulate and in the case of mast cell hyperplasia, more of these 
progenitors mature to form mast cells. Certain growth factors play a role in the 
increasing number of mast cells, but it has been found that a key component of this 
process is the influence of cytokines, specifically IL-3 and IL-4.  
 The increased levels of IL-13 during a type 2 response can promote goblet cell 
proliferation and hyperplasia. Goblet cells are secretory cells that help produce mucus 
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in the airways and parts of the GI tract. Goblet cells are typically a host defense cell that 
secretes mucus due to a number of stimuli, including inflammation. With normal levels, 
goblet cells are protective, but in the case of some type 2 responses, the increased IL-
13 can lead to goblet cell proliferation and hyperplasia, which if stimulated can lead to 
excess mucus which can block the airways. This is commonly seen in asthma and 
some allergic reactions, the airways constrict and with the excess mucus release, the 
airways become blocked, this can be fatal in some cases. However, in the GI tract, the 
excess mucus can provide a beneficial function, providing an extra layer of protection in 
times of inflammation. (18)  
 The final key characteristic in type 2 responses is the switching to IgE antibodies. 
IgE isotypes are typically only seen in the presence of allergic reactions or in parasite 
infections. IgE isotypes can activate mast cells to release their granules, but in some 
cases, this overactivation of mast cells can lead to a drop in blood pressure due to the 
vasodilator histamine. If excessive, this drop in blood pressure can lead to anaphylactic 
shock. 
 All of these responses occur in a typical type 2 response, and it is easy to see 
how, when these are uncontrolled or inappropriate, they can be damaging to the host. In 
moderation type 2 responses can be beneficial to the host but with certain diseases 
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 Helminth infections are typically labeled as a type 2 immune response, sharing 
many of the characteristics listed previously. What makes helminth infections different is 
that along with the type 2 response they also stimulate an immune regulatory network, 
which modulates an environment that promotes parasite survival without host expulsion 
(27). Helminths manipulate the host to create an environment that favors their survival, 
while limiting their detrimental effects. Some key components in the adaptive helminth 
response are the anti-inflammatory cytokines IL-10 and TGF-. Important cells for this 
response are Dendritic cells, alternatively activated macrophages, and T and B 
Regulatory cells. Collectively, these cells help to modulate the interactions between the 
parasite and host.  
Figure 1: Immune response to helminth infection triggers many changes. Th2 cells 
mediated many cellular changes. 
https://www.researchgate.net/figure/Immune-response-against-helminths-Helminth-infection-mainly-leads-to-Th2-
response_fig1_266086348  
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 IL-10 is a key anti-inflammatory cytokine that has been shown to have an 
immunosuppressive effect in both type 1 and type 2 immune responses. In type 1 
responses IL-10 is key in limiting the effects of Th1 and CD8+ cells which can be 
damaging if they are not regulated. In a murine study, it has been shown that mice 
devoid of IL-10 will succumb to lethal immune response due to overproduction of certain 
cytokines, that in moderate amounts have beneficial effects. In the case of helminth 
infections, IL-10 is upregulated, which helps to reduce inflammation and suppress the 
immune system. Parasites have adapted to the host, by ensuring the production of IL-
10 to keep the immune system at bay, to prevent their elimination or expulsion.  
 TGF- proteins belong to a large superfamily, that can have many different 
effects depending on the environment, receptors, and isoforms. TGF- generally has an 
immunosuppressive effect, but it also serves many other functions. (8) TGF- is an 
important mediator in many pathways that lead to the overall type 2 response. It also 
induces the maturation of T cells into Tregs. Others functions of TGF- are still being 
explored as well. 
 Dendritic cells play an important role in the stimulation and modulation of the 
immune system in helminth infections. Known as the professional antigen presenting 
cells, dendritic cells present T cells with parasite derived antigens, driving Th2 cell 
activation. In a study where dendritic cells were depleted, the type 2 immune response 
was not present after helminth infection (9). This shows that dendritic cells are a critical 
component in the parasite host interaction. Although there is a better understanding of 
how dendritic cells interact with type 1 responses, it is clear that they have a primary 
role in the type 2 response as well, however the specific pathway and mechanism have 
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not been defined. Dendritic cells have a magnitude of receptors and so far, many 
different receptors have been shown to play a role in the induction of pro-regulatory 
dendritic cells. What is known is that when dendritic cells are induced to the pro-
regulatory form, they act to promote type 1 regulatory (Tr1) cells, which produce the 
anti-inflammatory cytokine, IL-10. (1) 
 Alternatively activated macrophages (AAMs) are another key component of the 
helminth induced type 2 response. Differences in surface molecules and receptors are a 
main distinction between traditional macrophages and alternatively activated 
macrophages. AAMs are present in the type 2 response, and high levels have been 
detected in cases of helminth infection. Unlike traditional macrophages, AAMs have a 
suppressive effect on the immune system, modulated through anti-inflammatory agents 
such as IL-10, TGF-β, PD-L1 and PD-L2. Specific subtypes of AAMs have been 
identified but those specific to helminth infections are shown to be induced by IL-4 and 
IL-13. There has been some complications in trying to replicate the in vitro response to 
an in vivo response. However, what has been determined is that AAMs do increase IL-
10 production, whether this is a direct or indirect process is still up for debate. (11)  
 Regulatory T cells (Tregs) are critical to the permissive host immune response 
during parasite infection. Tregs are cells that typically control the immune response to 
self and some foreign antigens to prevent an autoimmune response. They act on other 
immune cells to suppress their activity in the presence of self antigens. After helminth 
infection, Treg populations expand as they are required for the long-term tolerance to 
the parasite. Tregs help control granuloma size in certain gut cells, and a reduction in 
granuloma size, means less inflammation when released. When Tregs numbers are 
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diminished by certain antibodies, an increase in granuloma size is seen (11). Much like 
we have seen before Tregs also produce IL-10, giving rise to the dampening of the 
inflammatory response. Tregs can be induced through the TGF-β pathway, interestingly 
it has been shown that inhibition of the TGF-β receptor, inhibits the induction of Tregs 
and parasites are expelled or in cases of chronic infection, the Type 2 response is 
increased (1). This shows the importance of Tregs in developing a symbiotic 
relationship with the host, and the importance of TGF-β in the response.  
 Regulatory B Cells (Bregs), although not as essential as Tregs, also play a role in 
the helminth induced type 2 immune response. Although B cells are typically known for 
antibody production, which typically leads to an increase in inflammation, some specific 
B cells present in helminth infections have suppressive effects. B10 cells or Bregs have 
experimentally been shown to be produced following certain parasite infections. Bregs 
are yet another source of IL-10 and also can produce IgG1 antibodies which can 
suppress granulomatous responses during chronic infections. (12)  
 
Type 2 Immune Pathologies : 
 Inflammatory bowel diseases like ulcerative colitis and Crohn’s Disease are 
characterized by repeated bouts of inflammation in the gut resulting in symptoms like 
diarrhea, weight loss and even malnourishment from low levels of nutrient absorption. 
These conditions are currently being studied and the underlying mechanisms are still 
somewhat unclear. These diseases are often chronic for patients and the treatment 
options that exist require lifelong medication. Due to the underlying mechanisms being 
unclear some patients fail to respond to the current medications, or over time notice a 
decrease in their responsiveness to them. (13) Although the underlying mechanisms are 
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unclear, what is known about inflammatory bowel diseases is that something triggers an 
inflammatory immune response in the gut, decreasing nutrient absorption. It has been 
hypothesized that bacteria, viruses, or antigens lead to the inflammation, or that a 
combination of these causes it. There has been recent evidence of a genetic factor that 
could lead to the development of the disease. Another common theory is that it is an 
autoimmune reaction which triggers the inflammation. If untreated or uncontrolled, the 
repeated bouts of inflammation can raise the patient’s susceptibility for colon cancer.  
 Allergies are a phenomenon where there is an intense type 2 response, resulting 
in varying levels of inflammation. The underlying mechanism with allergies is an 
inappropriate response to an allergen that typically is not harmful to the host. The 
symptoms arise from the response to the allergen, after a sensitization period. Common 
allergies like dust mites, and cat dander can cause low levels of respiratory 
inflammation and increased secretions. On the other end of the spectrum are some 
individuals whose response to tree nuts or insect venom lead to extreme inflammation 
and anaphylaxis. The allergen itself in normal cases has no effect on the host, but in 
these cases the host’s immune response to them is damaging. Excessive cytokine 
release and degranulation typically lead to the pathologies present in allergies.  
 
Hygiene Hypothesis: 
 The Hygiene Hypothesis is a phrase that has been derived from the collection of 
data showing correlations between the higher frequencies of allergies and some 
autoimmune diseases in well developed countries compared to developing countries. 
The improved standards of living have resulted in lower infection rates in children, while 
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at the same time increasing immune dysregulation. (1) The overall cleanliness in 
developed countries has many positive benefits, and the lower infection rates decrease 
infant mortality rates. However, problems like allergies and autoimmune diseases are 
much more prevalent in the well-developed countries.  
 A lot of research interest has been focused on the role of helminth infections and 
the correlating decrease in allergies and autoimmune diseases. Under-developed 
countries have a significantly higher incidence of helminth infections compared to well-
developed countries. Although it is not known what specifically ties these two 
phenomena together, there is positive correlation present. Allergies and autoimmune 
diseases are typically the result of auto-inflammation and the problems that arise when 
this is uncontrolled. Perhaps the symbiotic relationship of the parasite and host can 
provide a protective effect in the instance of these diseases. Most importantly, the anti-
inflammatory effects of IL-10 and other mediators could suppress the effects of these 
auto-inflammatory diseases.  
 
Helminth Therapy: 
 In cases of overreactive type 2 responses, there is theoretical evidence that co-
infection with a helminth parasite could lead to a suppression of the immune system, 
decreasing the severity and frequency of inflammatory bouts. In an indirect way the 
parasite’s manipulation of the host not only ensures its own survival but could also 
diminish the effects of other type 2 immune pathologies. Studies have shown to have 
many positive effects on the regulation of inflammatory and autoimmune disease.  
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 One early research study was done in a small community in Ecuador, in school-
aged children who were previously infected with Ascaris lumbricoides and Trichuris 
trichiura. Serum samples were collected initially and again two weeks after a 
anthelminthic treatment was given. Researchers tested the responsiveness of the 
basophils collected in the serum samples. Results showed that the basophils collected 
two weeks after the anthelminthic treatment were significantly more responsive to 
stimuli and released more histamine than the basophils collected before treatment. IgE 
levels were also measured and no change was detected in the pre and post treatment 
serum samples. This study may be naïve in nature but the increase in basophil 
responsiveness confirms that the presence of the helminth infection suppresses the 
immune system. Additionally, it hints that the continued stimulation of the helminth 
infection may be needed to see beneficial effects. Although the underlying mechanism 
of what specifically causes the decreased responsiveness is not yet understood, this 
gives a good macroscopic view of the potential benefits of helminth therapy.  
Figure 2: Basophil histamine release in infected children before and 2 weeks after 
anthelmintic treatment. (A) Histamine release in response to increasing concentration 
of Anti-IgE (B) Total serum IgE levels pre and post treatment  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387338/  
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 Although this first approach was novel, it still does not answer the question if 
helminths could be administered as a therapy. Another beneficial technique that arose 
was the administration of parasite eggs (ova) instead of infecting patients with whole 
parasites. Trichuris suis ova have been commonly used, and can elicit an immune 
response similar to a full parasitic infection. T. suis are parasites that infect pigs and are 
not pathogenic in humans. They are useful because they can partially stimulate the 
immune system while avoiding the risk of chronic infection. One downside with the ova 
administration is that they will not live and reproduce in the gut like traditional helminths 
would, so ova need to be administered every few weeks to maintain an adequate 
immune response. Additionally, ova can have significant side effects including diarrhea 
and GI disruption.  
 The first ova clinical trial was done with Trichuris suis ova and its effect on 
subjects with Crohn’s Disease. (21) 29 patients suffering from Crohn’s Disease were 
given 2,500 live Trichuris suis ova every 3 weeks for 24 weeks. Using detection 
methods specific for IBD’s, it was shown that 23/29 (79.3%) of patients responded to 
the therapy, and 21/29 (72.4%) met the criteria for disease remission. Results were 
similar when tested at 12 weeks, suggesting that patients develop a response to the 
treatment prior to the full 24 weeks that was tested. This novel study has given rise to 
many similar clinical trials. 
 After the results of the T. suis studies, the question that needed to be addressed 
was what specifically caused the decrease in inflammatory cytokines, and the 
mechanism for this “treatment”. These mechanisms were studied in animal models, and 
used a wide variety of parasites. Heligmosomoides polygyrus and Schistosoma 
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mansoni were two parasites that provided strong pathways and mechanisms for 
immune system suppression. H. polygyrus was studied in a murine model of IBD and its 
results were consistent with previous knowledge of disease protection, but furthered the 
details for the mode of action. Without parasite intervention, mice showed elevated 
levels of IL-12 and IFN-γ , both of which are common inflammatory mediators. Upon H. 
polygyrus infection inflammation was reduced significantly, also IL-12 and IFN-γ 
production was inhibited. What makes this research important was that it showed an IL-
10 independent pathway for the suppression of inflammation. IL-10 is still a very 
important factor, but this shows that it is not the only way helminths suppress the 
immune system. T cells were transferred to an IBD mouse from both a H. polygyrus 
host and a control host. Only the T cells from the host infected with H. polygyrus 
showed immunosuppressive effects. These mice had their IL-10 production knocked 
out, so the only variable was the source of the T cells. Upregulation of Foxp3 mRNA 
expression was shown to be present in the T cells from the helminth infected mouse 
only, and is responsible for the regulatory activity of the T cells. (22)  
 Research into the mechanisms of immune regulation have led to the discovery of 
the importance of Foxp3+ Regulatory T cells. Upon helminth infection, T cells are 
induced to express Foxp3, which gives them their specific regulatory functions. Foxp3+ 
T cells are one of the major factors for immune suppression after helminth infection. 
More recently a specific receptor, IL-4 Receptor alpha, has been shown to be essential 
in the differentiation into Foxp3+ Tregs. Adequate and functional IL-4 receptor alphas 
are required for inflammation control during helminth infections. (24)  
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 Another study looked at the specifics of Fasciola hepatica infection and the roles 
of IL-10 and TGF-β. Infection of the parasite suppressed the Th1 and Th2 responses of 
the host. This suppression was lost in mice with an IL-10 defect. Infection with the 
parasite also showed a bystander suppression of IFN-γ and IL-17. These are common 
mediators for inflammation in response to autoantigens. This suppression was still 
present in mice with the IL-10 defect, but the suppression was reversed in mice when 
TGF-β was neutralized. This shows again that there is not one specific pathway the 
parasite uses to suppress immune function, but in fact that they have integrated along 
many fronts. (23) 
 Most recently researchers are focusing on the use of parasite-derived products 
and parasite secretory products to elicit the same type 2 response and suppression. 
The goal with this research is to identify which components of the parasite interact with 
the host, and induce the immune response. Perhaps there is a specific secretory 
product that parasites expel which the host recognizes and induces a response. 
Identification of a specific product could lead to the pharmacological production of the 
product and an artificial induction of the host immune suppression without the need for 
introducing potentially pathogenic parasite material into the patient.  
 In a study with H. polygyrus, researchers looked at the specific H. polygyrus 
excretory-secretory antigen (HES) and it’s effect on the host. This specific protein was 
shown to induce Foxp3+ Tregs which had suppressive effects. More specifically HES 
ligated the TGF-β receptor on T cells. When this receptor was knocked out, all inducing 
effects induced by HES were eliminated. HES did not promote the development of Th1 
or Th2 reactions under any conditions. These findings indicate that HES specifically 
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may be responsible for the Foxp3+ induction of T cells. (25) This makes HES a potential 
candidate to be used as a helminth therapy. Knowing the direct mechanism of action of 
inducing Foxp3+ Tregs, outlines a direct pathway that can be manipulated. 
 Another interesting secretory protein is ES-62 from filarial nematodes. ES-62 is a 
protein that was found to have multiple inducing effects, across a wide range of cells 
including macrophages, dendritic cells, B-cells and mast cells. Upon complexing with 
TLR4, ES-62 results in the modulation of many signal transduction pathways. The net 
effect of these pathway modulations is the generation of the anti-inflammatory immune 
response. The multi functionality of the modulating protein makes it an interesting 
protein to study for the development of pharmaceuticals that can target these same 
signal transduction pathways. (26) 
 New excretory proteins are being studied in the hope of identifying a specific 
pathway that can be manipulated to lead to immune suppression for inflammatory 
diseases. When identified these can be produced by biopharmaceutical techniques and 
hopefully be used to prevent unwanted inflammation and inappropriate antigen 
stimulation. It is critical to understand the mechanism of action for the specific proteins 
that will be used, to avoid unwanted systemic effects.  
 In these clinical trials very low doses of parasites or parasite derived products are 
used to ensure the safety of the subject. This can have an effect on conclusions 
because it makes it very difficult to match a control group. Those who receive the 
helminth therapy will experience side effects, and the placebo group will not, so the 
double-blinded nature of the study is in question. As research moves forward, limiting 
these side effects will help lead to more conclusive studies.  




 Over years of co-evolution it is clear that parasites have been able to manipulate 
their host’s immune system to ensure their survival. This process is done on many 
fronts, and there is not one specific mechanism that controls the host regulation of the 
parasite. It is clear that the suppression of the host’s immune system can have added 
benefits in the presence of auto-inflammatory diseases. These interactions are being 
studied in the hopes to isolate a specific protein or mediator that provides the beneficial 
effects on its own. Future efforts will hopefully lead to potential interventions for 


















  Horak18 
 
References:  
(1) McSorley, H. J., & Maizels, R. M. (2012). Helminth infections and host immune 
regulation. Clinical microbiology reviews, 25(4), 585–608.  
 
(2) Lechner, C. J., Komander, K., Hegewald, J., Huang, X., Gantin, R. G., Soboslay, P. 
T., Agossou, A., Banla, M., & Köhler, C. (2013). Cytokine and chemokine responses to 
helminth and protozoan parasites and to fungus and mite allergens in neonates, 
children, adults, and the elderly. Immunity & ageing : I & A, 10(1), 29.  
 
(3) A. H. van den Biggelaar, R. van Ree, L. C. Rodrigues et al., “Decreased atopy in 
children infected with Schistosoma haematobium: a role for parasite-induced 
interleukin-10,” The Lancet, vol. 356, no. 9243, pp. 1723–1727, 2000. 
 
(4) Couper, Kevin N., et al. “IL-10: The Master Regulator of Immunity to Infection.” The 
Journal of Immunology, American Association of Immunologists, 1 May 2008,  
 
(5) Larson, D., Cooper, P. J., Hübner, M. P., Reyes, J., Vaca, M., Chico, M., Kong, H. 
H., & Mitre, E. (2012). Helminth infection is associated with decreased basophil 
responsiveness in human beings. The Journal of allergy and clinical immunology, 
130(1), 270–272.  
 
(6) Caminati, M., Pham, D., Bagnasco, D. et al. Type 2 immunity in asthma. World 
Allergy Organ J 11, 13 (2018).   
 
(7) Gazzinelli, R. T., M. Wysocka, S. Hieny, T. Scharton-Kersten, A. Cheever, R. Kuhn, 
W. Muller, G. Trinchieri, A. Sher. 1996. In the absence of endogenous IL-10, mice 
acutely infected with Toxoplasma gondii succumb to a lethal immune response 
dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ and 
TNF-α. J. Immunol. 157: 798-805.  
 
(8) Chin D., Boyle G. M., Parsons P. G., Coman W. B. What is transforming growth 
factor-beta (TGF-β)? British Journal of Plastic Surgery. 2004;57(3):215–221. doi: 
10.1016/j.bjps.2003.12.012.  
 
(9) Carvalho L, et al. 2009. Mechanisms underlying helminth modulation of dendritic cell 
function. Immunology 126:28 –34.  
 
  Horak19 
 
(10) Kreider, T., Anthony, R. M., Urban, J. F., Jr, & Gause, W. C. (2007). Alternatively 
activated macrophages in helminth infections. Current opinion in immunology, 19(4), 
448–453.  
 
(11) Layland LE, Rad R, Wagner H, da Costa CU. 2007. Immunopathology in 
schistosomiasis is controlled by antigen-specific regulatory T cells primed in the 
presence of TLR2. Eur. J. Immunol. 37:2174 –2184. 
 
(12) FairfaxKC,etal.2012.IL-10Rblockadeduringchronicschistosomiasis 
mansoni results in the loss of B cells from the liver and the development of severe 
pulmonary disease. PLoS Pathog. 8:e1002490. doi:10.1371/ journal.ppat.1002490. 
 
(13) Hazel, K., & O'Connor, A. (2020). Emerging treatments for inflammatory bowel 
disease. Therapeutic advances in chronic disease, 11, 2040622319899297. 
 
(14) Kovalszki, A., & Weller, P. F. (2016). Eosinophilia. Primary care, 43(4), 607–617.  
 
(15) Spencer, L. A., & Weller, P. F. (2010). Eosinophils and Th2 immunity: 
contemporary insights. Immunology and cell biology, 88(3), 250–256.  
 
(16) Sabin EA, Pearce EJ. Early IL-4 production by non-CD4+ cells at the site of antigen 
deposition predicts the development of a T helper 2 cell response to Schistosoma 
mansoni eggs. J Immunol. 1995;155:4844–4853. 
 
(17) Bischoff SC, Sellge G. Mast cell hyperplasia: role of cytokines. Int Arch Allergy 
Immunol. 2002;127:118–122.  
 
(18) Rogers DF. Airway goblet cells: responsive and adaptable front-line defenders. Eur 
Respir J 1994;7:1690–1706.  
 
(19) Schnoeller C, et al. 2008. A helminth immunomodulator reduces aller- gic and 
inflammatory responses by induction of IL-10-producing mac- rophages. J. Immunol. 
180:4265– 4272. 
 
(20) Grainger JR, et al. 2010. Helminth secretions induce de novo T cell 
Foxp3 expression and regulatory function through the TGF-􏰂 pathway. 
J. Exp. Med. 207:2331–2341.  
 
  Horak20 
 
(21) Summers RW, et al. 2003. Trichuris suis seems to be safe and possibly effective in 
the treatment of inflammatory bowel disease. Am. J. Gastro- enterol. 98:2034 –2041  
 
(22) Elliott DE, et al. 2004. Heligmosomoides polygyrus inhibits established 
colitis in IL-10-deficient mice. Eur. J. Immunol. 34:2690 –2698.  
 
(23) Walsh KP, Brady MT, Finlay CM, Boon L, Mills KHG. 2009. Infection with a 
helminth parasite attenuates autoimmunity through TGF-􏰂- mediated suppression of 
Th17 and Th1 responses. J. Immunol. 183: 1577–1586. 
 
(24) Abdel Aziz, N., Nono, J. K., Mpotje, T., & Brombacher, F. (2018). The Foxp3+ 
regulatory T-cell population requires IL-4Rα signaling to control inflammation during 
helminth infections. PLoS biology, 16(10), e2005850. 
 
(25) Grainger, J. R., Smith, K. A., Hewitson, J. P., McSorley, H. J., Harcus, Y., Filbey, K. 
J., Finney, C. A., Greenwood, E. J., Knox, D. P., Wilson, M. S., Belkaid, Y., Rudensky, 
A. Y., & Maizels, R. M. (2010). Helminth secretions induce de novo T cell Foxp3 
expression and regulatory function through the TGF-β pathway. The Journal of 
experimental medicine, 207(11), 2331–2341. 
 
(26) Harnett W, Harnett MM. 2009. Immunomodulatory activity and ther- apeutic 
potential of the filarial nematode secreted product, ES-62. Adv. Exp. Med. Biol. 666:88 –
94.   
 
(27) Resende, S. D., Magalhães, F. C., Rodrigues-Oliveira, J. L., Castro, V. N., Souza, 
C., Oliveira, E. J., Carneiro, M., Geiger, S. M., & Negrão-Corrêa, D. A. (2019). 
Modulation of Allergic Reactivity in Humans Is Dependent on Schistosoma mansoni 
Parasite Burden, Low Levels of IL-33 or TNF-α and High Levels of IL-10 in Serum. 
Frontiers in immunology, 9, 3158. 
